NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



New molecular classification predicts response to chemotherapy



December 28th, 2004

Different molecular subtypes of breast cancer respond differently to chemotherapy, a research team from The University of Texas M.D. Anderson Cancer Center reported on December 8, 2004, at the annual San Antonio Breast Cancer Symposium meeting.

The findings reinforce the emerging notion that breast cancer should be classified according to its gene expression profile in order to make accurate predictions about the outcome of the disease and select the optimal treatment for patients, says the senior investigator, Lajos Pusztai, MD, PhD, an associate professor in the Department of Breast Medical Oncology.

Four major molecular subgroups of breast cancer...


Source: Cancer Weekly (2004-12-28)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login